Latest Share Chat

REMOVE ADS

Angle Share News (AGL)

Angle Information

There is currently no data for AGL

REMOVE ADS

Angle News

Angle raises £1.2m, swings to a half-year loss

Technology investment company ANGLE has raised £1.2m through a fundraising on the same that it revealed it had swung to a loss in the first half ended...

Angle makes important step in cancer technology

Angle's 90%-owned portfolio company, Parsortix, which specialises in medical diagnostics, has used its cell separation device to successfully capture ...

Angle shares storm north on Parsortix lung cancer result

Angle, the technology investment company, saw its share price go vertical on Friday morning on the back of success at one its investments, Parsortix. ...

Angle reports further delays on IVF product

Shares in Angle, the Surrey-based technology investment firm, fell today after it reported delays to its IVF product EmbryoSure. The embryo viability...

Angle prostate cancer test sees shares rocket

Angle, the Surrey-based technology investment firm, has seen its share price rocket nearly 15% on news one of its divisions has found a new way to det...

Angle buys 90% stake in cancer diagnostic firm

Angle has increased its stake in its subsidiary, Parsotix, to 90% following the success of the cancer diagnostic firm's cell separation device. The ...

Angle announces new cancer detection device

Technology firm Angle has announced that Parsortix, its 85% owned portfolio company which specialises in medical diagnostics, has achieved a major mil...

Angle rises sharply on patent award

Technology firm incubator Angle saw an acute increase in its share price after one of its subsidiaries was granted a US patent. Angle's 83% owned med...